Max Healthcare Institute Limited
NSE:MAXHEALTH.NS
984.85 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 54,060.2 | 45,626 | 38,831.9 | 24,824.1 | 18,617.1 | 16,714.4 | 17,116.3 | 14,379.5 | 12,568.2 | 7,895.7 | 9,444.6 |
| Cost of Revenue
| 34,147.9 | 9,220.1 | 9,229 | 5,944.1 | 3,917.8 | 3,654.6 | 4,493.9 | 4,231 | 3,987.1 | 4,363.7 | 5,387.9 |
| Gross Profit
| 19,912.3 | 36,405.9 | 29,602.9 | 18,880 | 14,699.3 | 13,059.8 | 12,622.4 | 10,148.5 | 8,581.1 | 3,532 | 4,056.7 |
| Gross Profit Ratio
| 0.368 | 0.798 | 0.762 | 0.761 | 0.79 | 0.781 | 0.737 | 0.706 | 0.683 | 0.447 | 0.43 |
| Reseach & Development Expenses
| 36.7 | 3.6 | -1,598.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 11,168.9 | 9,863.1 | 9,081.9 | 5,832.5 | 4,924.5 | 4,556.8 | 4,467.9 | 4,160.8 | 3,803.5 | 252.5 | 0 |
| Selling & Marketing Expenses
| -3,728 | 575.5 | 446.2 | 167.5 | 254.5 | 217.1 | 319.5 | 291.1 | 283 | 156.2 | 132.2 |
| SG&A
| 7,440.9 | 9,863.1 | 9,528.1 | 6,000 | 5,179 | 4,773.9 | 4,787.4 | 4,451.9 | 4,086.5 | 408.7 | 132.2 |
| Other Expenses
| 218.7 | 268.6 | 109.6 | 100 | 84.5 | 65.4 | 7,589.9 | 108.7 | 111.8 | 0 | 0 |
| Operating Expenses
| 7,440.9 | 26,322.5 | 21,848.4 | 16,040.8 | 12,910.9 | 12,499 | 12,377.3 | 9,569.3 | 8,434.6 | 3,790.7 | 4,273.9 |
| Operating Income
| 12,471.4 | 10,240.2 | 7,579.6 | 2,430.5 | 482.2 | 569.1 | 650.8 | 1,007 | 430.5 | -276.3 | -231.3 |
| Operating Income Ratio
| 0.231 | 0.224 | 0.195 | 0.098 | 0.026 | 0.034 | 0.038 | 0.07 | 0.034 | -0.035 | -0.024 |
| Total Other Income Expenses Net
| 1,181.8 | 397 | -190.6 | -3,347.5 | 106.4 | -485.9 | -915.7 | -960 | -620.1 | -105.1 | -411.6 |
| Income Before Tax
| 13,653.2 | 10,637.2 | 7,389 | -686.5 | 890.8 | 83.2 | -264.9 | 47 | -189.6 | -381.4 | -642.9 |
| Income Before Tax Ratio
| 0.253 | 0.233 | 0.19 | -0.028 | 0.048 | 0.005 | -0.015 | 0.003 | -0.015 | -0.048 | -0.068 |
| Income Tax Expense
| 3,076.8 | -397.9 | 1,338.5 | 458.5 | -62.6 | 85.1 | 22.4 | -43.5 | 36.5 | 0 | 3.6 |
| Net Income
| 10,576.4 | 11,035.1 | 6,050.5 | -1,375.5 | 953.4 | -30.1 | -287.3 | 90.5 | -226.1 | -381.4 | -646.5 |
| Net Income Ratio
| 0.196 | 0.242 | 0.156 | -0.055 | 0.051 | -0.002 | -0.017 | 0.006 | -0.018 | -0.048 | -0.068 |
| EPS
| 10.89 | 11.38 | 6.25 | -1.59 | 1.77 | -0.056 | -0.53 | 0.17 | -0.41 | -0.85 | -1.57 |
| EPS Diluted
| 10.84 | 11.36 | 6.24 | -1.59 | 1.77 | -0.055 | -0.53 | 0.17 | -0.41 | -0.85 | -1.57 |
| EBITDA
| 14,921.2 | 13,797.7 | 10,714.2 | 5,541.6 | 3,561.5 | 2,080.2 | 1,624.7 | 2,083.1 | 1,342.6 | 218.1 | 283.2 |
| EBITDA Ratio
| 0.276 | 0.302 | 0.276 | 0.223 | 0.191 | 0.124 | 0.095 | 0.145 | 0.107 | 0.028 | 0.03 |